文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

巴西男男性行为者和跨性别女性中青少年对事件驱动型和长效注射用暴露前预防药物的知晓率及使用意愿:一项横断面研究

Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross-sectional study.

作者信息

Magno Laio, Leite Beo Oliveira, Grangeiro Alexandre, Dezanet Lorenza, Soares Fabiane, Dourado Inês

机构信息

Departamento de Ciências da Vida, Universidade do Estado da Bahia, Salvador, Brazil.

Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil.

出版信息

J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26479. doi: 10.1002/jia2.26479.


DOI:10.1002/jia2.26479
PMID:40600470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12215819/
Abstract

INTRODUCTION: New pre-exposure prophylaxis (PrEP) options, including event-driven and long-acting injectable, may enhance HIV prevention strategies among adolescents and youth. This study examined awareness and intention to use event-driven and long-acting injectable PrEP, along with associated factors, among adolescent and young men who have sex with men and transgender women. METHODS: A cross-sectional study was conducted between December 2020 and February 2022 among men who have sex with men and young transgender women aged 15-20 years, who participated in a daily oral PrEP cohort study in Salvador and São Paulo, Brazil. Binomial logistic regression models analysed factors associated with the intention to use event-driven and long-acting injectable PrEP. RESULTS: A total of 1221 participants were enrolled in the cohort at the time of this analysis, with 597 responding to the survey. Awareness of event-driven and long-acting injectable PrEP was reported by 15.3% and 18.0% of participants, respectively. Intention to use event-driven PrEP was reported by 56.4% of participants, while 81.5% expressed intention to use long-acting injectable PrEP. Participants with lower and moderate adherence to daily oral PrEP were more likely to intend to use event-driven PrEP (OR = 1.79; 95% CI: 1.04-3.08), whereas those who reported always or often using condoms in insertive anal sex with steady or casual partners were less likely to intend to use event-driven PrEP (OR = 0.37; 95% CI: 0.15-0.90). For long-acting injectable PrEP, participants with middle (OR = 1.93; 95% CI: 1.05-3.53) or low socio-economic status (OR = 3.13; 95% CI: 1.30-7.51) and those reporting three or more casual partners in the past 3 months (OR = 2.25; 95% CI: 1.30-3.89) were more likely to intend to use long-acting injectable PrEP. Conversely, participants who had never used daily oral PrEP were less likely to intend to use long-acting injectable PrEP (OR = 0.31; 95% CI: 0.11-0.92). CONCLUSIONS: Adolescents and young people in Brazil demonstrated a stronger preference for long-acting injectable over event-driven PrEP, with sexual behaviour patterns significantly influencing choices. Expanding prevention options may enhance PrEP uptake and adherence, improving HIV prevention strategies among adolescents and young adults.

摘要

引言:新的暴露前预防(PrEP)方案,包括事件驱动型和长效注射型,可能会增强青少年和青年群体中的艾滋病预防策略。本研究调查了男男性行为者和变性女性中对事件驱动型和长效注射型PrEP的知晓情况、使用意愿以及相关因素。 方法:2020年12月至2022年2月期间,在巴西萨尔瓦多和圣保罗参与每日口服PrEP队列研究的15至20岁男男性行为者和年轻变性女性中开展了一项横断面研究。采用二项逻辑回归模型分析与使用事件驱动型和长效注射型PrEP意愿相关的因素。 结果:在本次分析时,共有1221名参与者纳入该队列,其中597人回应了调查。分别有15.3%和18.0%的参与者知晓事件驱动型和长效注射型PrEP。56.4%的参与者表示有使用事件驱动型PrEP的意愿,而81.5%的参与者表示有使用长效注射型PrEP的意愿。对每日口服PrEP依从性较低和中等的参与者更有可能打算使用事件驱动型PrEP(比值比[OR]=1.79;95%置信区间[CI]:1.04 - 3.08),而那些报告在与固定或临时伴侣进行插入式肛交时总是或经常使用避孕套的参与者打算使用事件驱动型PrEP的可能性较小(OR = 0.37;95% CI:0.15 - 0.90)。对于长效注射型PrEP,社会经济地位中等(OR = 1.93;95% CI:1.05 - 3.53)或较低(OR = 3.13;95% CI:1.30 - 7.51)以及在过去3个月内报告有三个或更多临时伴侣的参与者更有可能打算使用长效注射型PrEP。相反,从未使用过每日口服PrEP的参与者打算使用长效注射型PrEP的可能性较小(OR = 0.31;95% CI:0.11 - 0.92)。 结论:巴西的青少年和年轻人对长效注射型PrEP的偏好高于事件驱动型PrEP,性行为模式对选择有显著影响。扩大预防方案可能会提高PrEP的接受度和依从性,改善青少年和青年成年人中的艾滋病预防策略。

相似文献

[1]
Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross-sectional study.

J Int AIDS Soc. 2025-7

[2]
PrEP15-19 Choices: an implementation study protocol of HIV prevention with oral and long-acting injectable cabotegravir PrEP in real-word settings among sexual and gender minority adolescents in Brazil.

BMJ Open. 2025-1-20

[3]
Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024.

Euro Surveill. 2025-7

[4]
Reconciling advantages and difficulties: knowledge and perceptions of event-driven PrEP among young people.

Rev Saude Publica. 2024

[5]
Impact of changing pre-exposure prophylaxis regimens on retention among men who have sex with men in Hanoi, Vietnam (2020-2023): a cohort study.

J Int AIDS Soc. 2025-7

[6]
Interest in Oral Pre-exposure Prophylaxis Among Men Who Have Sex with Men and Transfeminine Persons in HPTN 075, a Multi-center HIV Prevention Study in Sub-Saharan Africa (2015-2017).

AIDS Behav. 2025-2

[7]
The Effects of MyChoices and LYNX Mobile Apps on HIV Testing and Pre-Exposure Prophylaxis Use by Young US Sexual Minority Men: Results From a National Randomized Controlled Trial.

JMIR Public Health Surveill. 2025-2-5

[8]
Factors associated with PrEP use in a community sample of African American men who have sex with men (MSM) and transgender women (TGW) in the United States Midwest.

AIDS Care. 2024-7

[9]
Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data.

J Int AIDS Soc. 2022-3

[10]
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.

Cochrane Database Syst Rev. 2008-7-16

引用本文的文献

[1]
Awareness and acceptability of long-acting injectable pre-exposure prophylaxis for HIV prevention among female students at tertiary learning institutions: a multi-center, institution-based cross-sectional study.

BMC Public Health. 2025-7-17

[2]
Expanding access to a choice-based multi-method PrEP market for HIV prevention.

J Int AIDS Soc. 2025-7

本文引用的文献

[1]
PrEP15-19 Choices: an implementation study protocol of HIV prevention with oral and long-acting injectable cabotegravir PrEP in real-word settings among sexual and gender minority adolescents in Brazil.

BMJ Open. 2025-1-20

[2]
Performance of indirect adherence measures for daily oral pre-exposure prophylaxis for HIV among adolescent men who have sex with men and transgender women in Brazil.

PLoS One. 2024-12-31

[3]
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.

N Engl J Med. 2024-10-3

[4]
Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study.

JMIR Public Health Surveill. 2023-4-19

[5]
Factors associated to HIV prevalence among adolescent men who have sex with men in Salvador, Bahia State, Brazil: baseline data from the PrEP1519 cohort.

Cad Saude Publica. 2023

[6]
Interdisciplinarity in HIV prevention research: the experience of the PrEP1519 study protocol among adolescent MSM and TGW in Brazil.

Cad Saude Publica. 2023

[7]
Preferences for pre-exposure prophylaxis (PrEP) among sexual and gender minorities: a discrete choice experiment in Brazil.

Lancet Reg Health Am. 2023-2-6

[8]
Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil.

BMC Public Health. 2022-9-12

[9]
Reaching Out to Adolescents at High Risk of HIV Infection in Brazil: Demand Creation Strategies for PrEP and Other HIV Combination Prevention Methods.

Arch Sex Behav. 2023-2

[10]
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.

Lancet HIV. 2022-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索